Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
C-Vitum is a dietary supplement brand developed by the Polish company Oleofarm, featuring L-ascorbic acid (vitamin C) as its active ingredient. It is primarily indicated for the treatment and prevention of vitamin C deficiency and for general nutritional supplementation. Vitamin C serves as a critical antioxidant, protecting cellular components from oxidative damage, and acts as a necessary cofactor for enzymes such as prolyl and lysyl hydroxylases, which are essential for the biosynthesis of collagen. This support for collagen production is vital for the structural integrity of skin, blood vessels, bones, and cartilage. C-Vitum is available in several oral delivery formats, including high-potency capsules, effervescent tablets, and prolonged-release formulations, to support immune health, nervous system function, and energy metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on C-Vitum.